In patients with advanced ovarian cancer, primary suboptimal surgery has better survival outcome than interval suboptimal surgery

OBJECTIVE: It is known that optimal or complete cytoreduction is the most important factor in patients with advanced ovarian cancer. The aim of this study was to examine the results of patients who did not undergo optimal cytoreduction and to examine subgroup analysis based on neoadjuvant chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaban, Alpaslan, Topuz, Samet, Saip, Pınar, Sözen, Hamdullah, Salihoğlu, Yavuz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501870/
https://www.ncbi.nlm.nih.gov/pubmed/29545229
http://dx.doi.org/10.4274/jtgga.galenos.2018.2018.0015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501870/
https://www.ncbi.nlm.nih.gov/pubmed/29545229
http://dx.doi.org/10.4274/jtgga.galenos.2018.2018.0015

Ejemplares similares